Sanofi reported €2.86B in Cost of Sales for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Amarin AMRN:US $ 33.07M 4.27M
Amgen AMGN:US $ 1488M 25M
AstraZeneca AZN:LN 1361M 393M
Bayer BAYN:GR € 4018M 638M
Biogen BIIB:US $ 449.1M 38M
BMW BMW:GR € 18682M 1036M
Bristol Myers Squibb BMY:US $ 2675M 978M
Daimler DAI:GR € 32295M 5780M
Eli Lilly And LLY:US $ 1222M 6.9M
Fresenius FRE:GR € 6369M 83M
Fresenius Medical Care FME:GR € 3121M 44M
Gilead Sciences GILD:US $ 1064M 95M
GlaxoSmithKline GSK:LN 2429M 352M
Johnson & Johnson JNJ:US $ 6940M 383M
Merck MRK:GR € 1610M 44M
Merk MRK:US $ 3134M 110M
Pfizer PFE:US $ 2232M 114M
Recordati REC:IM 86.24M 39.27M
Regeneron Pharmaceuticals REGN:US $ 275.5M 58.2M
SAP SAP:GR € 1829M 135M
Volkswagen VOW3:GR € 37030M 8616M